Shilpa Medicare Ltd's Finished Dosage Formulation Facility (Sterile and Non-sterile) located at S-20 to S-26, Pharmaceutical Formulations SEZ, TSIIC, Jadcherla, Telangana State, India has been issued GMP certification by Ministry of Industry and Trade of the Russian Federation for the GMP inspection held from 22-02-2021 to 26-02-2021. There were No Critical, Major and Minor observations found during GMP inspection process.

The GMP certificate is valid for three years until April 2024.